JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 87: 2896-2903, 2002;
0022-3077/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avshalumov, M. V.
Right arrow Articles by Rice, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avshalumov, M. V.
Right arrow Articles by Rice, M. E.

The Journal of Neurophysiology Vol. 87 No. 6 June 2002, pp. 2896-2903
Copyright ©2002 by the American Physiological Society

NMDA Receptor Activation Mediates Hydrogen Peroxide-Induced Pathophysiology in Rat Hippocampal Slices

Marat V. Avshalumov and Margaret E. Rice

Departments of Physiology and Neuroscience and Neurosurgery, New York University School of Medicine, New York, New York 10016

Avshalumov, Marat V. and Margaret E. Rice. NMDA Receptor Activation Mediates Hydrogen Peroxide-Induced Pathophysiology in Rat Hippocampal Slices. J. Neurophysiol. 87: 2896-2903, 2002. Endogenous reactive oxygen species (ROS) can act as modulators of neuronal activity, including synaptic transmission. Inherent in this process, however, is the potential for oxidative damage if the balance between ROS production and regulation becomes disrupted. Here we report that inhibition of synaptic transmission in rat hippocampal slices by H2O2 can be followed by electrical hyperexcitability when transmission returns during H2O2 washout. As in previous studies, H2O2 exposure (15 min) reversibly depressed the extracellular population spike (PS) evoked by Schaffer collateral stimulation. Recovery of PS amplitude, however, was typically accompanied by mild epileptiform activity. Inclusion of ascorbate (400 µM) during H2O2 washout prevented this pathophysiology. No protection was seen with isoascorbate, which is a poor substrate for the stereoselective ascorbate transporter and thus remains primarily extracellular. Epileptiform activity was also prevented by the N-methyl-D-aspartate (NMDA) receptor antagonist, DL-2-amino-5-phosphonopentanoic acid (AP5) during H2O2 washout. Once hyperexcitability was induced, however, AP5 did not reverse it. When present during H2O2 exposure, AP5 did not alter PS depression by H2O2 but did inhibit the recovery of PS amplitude seen during pulse-train stimulation (10 Hz, 5 s) in H2O2. Inhibition of glutamate uptake by l-trans-2,4-pyrrolidine dicarboxylate (PDC; 50 µM) during H2O2 washout markedly enhanced epileptiform activity; coapplication of ascorbate with PDC prevented this. These data indicate that H2O2 exposure can cause activation of normally silent NMDA receptors, possibly via inhibition of redox-sensitive glutamate uptake. When synaptic transmission returns during H2O2 washout, enhanced NMDA receptor activity leads to ROS generation and consequent oxidative damage. These data reveal a pathological cycle that could contribute to progressive degeneration in neurological disorders that involve oxidative stress, including cerebral ischemia.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
C.-C. Yang, C.-T. Chien, M.-H. Wu, M.-C. Ma, and C.-F. Chen
NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1433 - F1440.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R.E. Gonsette
Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
Multiple Sclerosis, January 1, 2008; 14(1): 22 - 34.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online